Therapy for Secondary CNS Involvement in Malignant Lymphomas: No Standard Yet!
J Clin Oncol
.
2016 May 20;34(15):1829-30.
doi: 10.1200/JCO.2015.65.0879.
Epub 2016 Mar 21.
Authors
Agnieszka Korfel
1
,
Marc Chamberlain
2
,
Ed Neuwelt
3
,
Eckhard Thiel
4
,
Nancy Doolittle
3
,
Uwe Schlegel
5
,
Martin Dreyling
6
,
James Rubenstein
7
,
Lars Fischer
4
,
Magnus Björkholm
8
,
Peter Martus
9
,
Michael Weller
10
,
Michael Glantz
11
Affiliations
1
Charite University Medicine Berlin, Berlin, Germany agnieszka.korfel@charite.de.
2
University of Washington, Seattle, WA.
3
Oregon Health and Science University, Portland, OR.
4
Charite University Medicine Berlin, Berlin, Germany.
5
Ruhr-Universität Bochum, Bochum, Germany.
6
University Hospital München, Großhadern, Germany.
7
University of California, San Francisco, San Francisco, CA.
8
Karolinska University Hospital Stockholm, Sweden.
9
University Tuebingen, Tuebingen, Germany.
10
University Hospital Zürich, Zürich, Switzerland.
11
Penn State College of Medicine, Hershey, PA.
PMID:
27001566
PMCID:
PMC5321044
DOI:
10.1200/JCO.2015.65.0879
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Central Nervous System Neoplasms*
Humans
Lymphoma*
Neoplasms, Second Primary
Grants and funding
R01 CA139083/CA/NCI NIH HHS/United States
R21 CA184694/CA/NCI NIH HHS/United States